Although the AI tools are promising and have the potential to improve the diagnostic accuracy and monitoring in asthma, experts caution that these tools need more testing. Most studies remain proof-of-concept, with limited external validation and little evidence of clinical impact, writes Science Writer Vanita Srivastava.
Vanita Srivastava is an Independent Science and Health Writer. She specializes in medicine and healthcare, healthcare technology, and digital health, with a focus on telehealth and wellness topics. Her work has been featured in prominent publications such as Fortune India, moneycontrol.com, Outlook Publishing (India) Pvt. Ltd., CNBC-TV18, and Nature Portfolio.











